Xylem (XYL) director Ellis receives 1,711 RSU award, now holds 6,038 shares

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

ELLIS EARL RAY reported acquisition or exercise transactions in this Form 4 filing.

Xylem Inc. director Earl Ray Ellis reported receiving an award of 1,711 shares of common stock as restricted stock units valued at $116.88 per share. These RSUs are scheduled to vest in full on the trading day before the company’s 2027 Annual Meeting of Shareholders.

Ellis has elected to defer settlement of this RSU award until Separation of Service, meaning the actual share delivery is postponed until he leaves service. After this grant and dividend reinvestment adjustments, he now directly holds 6,038 shares of Xylem common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider ELLIS EARL RAY

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,711	$116.88	$200K

Holdings After Transaction: Common Stock — 6,038 shares (Direct, null)

Footnotes (1)

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU award until Separation of Service. Includes additional shares due to dividend reinvestment.

Key Figures

RSU grant size: 1,711 shares Grant reference price: $116.88 per share Post-grant holdings: 6,038 shares +1 more

4 metrics

RSU grant size 1,711 shares Restricted stock units of common stock granted to director

Grant reference price $116.88 per share Value per share used for RSU award reporting

Post-grant holdings 6,038 shares Total Xylem common shares held directly after transaction

Vesting timing Trading day before 2027 meeting RSUs vest before the 2027 Annual Meeting of Shareholders

Key Terms

restricted stock units, Xylem 2011 Omnibus Incentive Plan, dividend reinvestment, Separation of Service

4 terms

restricted stock units financial

"Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Xylem 2011 Omnibus Incentive Plan financial

"pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016)"

dividend reinvestment financial

"Includes additional shares due to dividend reinvestment."

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

Separation of Service financial

"The Reporting Person has elected to defer the settlement of the RSU award until Separation of Service."

Form 4 Insider Transactions: What Each Field Means →

05/15/2026 - 04:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ELLIS EARL RAY

(Last)

(First)

(Middle)

C/O XYLEM INC.

301 WATER STREET SE

(Street)

WASHINGTON

DISTRICT OF COLUMBIA

20003

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Xylem Inc. [ XYL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/14/2026		A		1,711⁽¹⁾	A	$116.88	6,038⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU award until Separation of Service.

2. Includes additional shares due to dividend reinvestment.

	/s/ Mike Nazario, by power of attorney for Earl R. Ellis	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Xylem (XYL) director Earl Ray Ellis report on this Form 4?

Earl Ray Ellis reported receiving 1,711 restricted stock units of Xylem common stock at a reference value of $116.88 per share. This is a compensation-related equity award, not an open-market stock purchase or sale, and increases his direct Xylem holdings.

How many Xylem (XYL) shares does Earl Ray Ellis hold after the RSU grant?

After the restricted stock unit grant, Earl Ray Ellis directly holds 6,038 shares of Xylem common stock. This total includes the new 1,711-share RSU award and additional shares credited from dividend reinvestment, as disclosed in the Form 4 footnotes.

When do Earl Ray Ellis’s new Xylem (XYL) RSUs vest?

The 1,711 restricted stock units are scheduled to vest in full on the trading day before Xylem’s 2027 Annual Meeting of Shareholders. Until vesting, the award remains subject to the plan’s terms described in the Xylem 2011 Omnibus Incentive Plan.

Did Earl Ray Ellis defer settlement of his Xylem (XYL) RSU award?

Yes. Ellis elected to defer settlement of the 1,711-share restricted stock unit award until Separation of Service. This means the RSUs will vest as scheduled, but actual share delivery will occur when he leaves service with Xylem under the plan’s rules.

Are dividend reinvestments included in Earl Ray Ellis’s Xylem (XYL) holdings?

Yes. The filing notes that his reported 6,038-share direct holding includes additional shares from dividend reinvestment. These reinvested dividends increased his share count beyond the original equity awards, as specifically indicated in the Form 4 footnotes.

Is this Xylem (XYL) Form 4 a market buy or sell by Earl Ray Ellis?

No. The Form 4 records a grant of 1,711 restricted stock units as compensation, coded as an acquisition (A) for a grant or award. It does not reflect an open-market purchase or sale of Xylem shares by Ellis.